ABSTRACT Pluripotent cells of the blastocyst inner cell mass (ICM) and their in vitro derivatives, embryonic stem (ES) cells, contain genomes in an epigenetic state that are poised for subsequent differentiation. Their chromatin is hyperdynamic in nature and relatively uncondensed. In addition, a large number of genes are expressed at low levels in both ICM and ES cells. Also, the chromatin of naturally pluripotent cells contains specialized histone modification patterns such as bivalent domains, which mark genes destined for later developmentally-regulated expression states. Female pluripotent cells contain X chromosomes that have yet to undergo the process of X chromosome inactivation. Collectively, these features of very early embyronic chromatin are required for the successful specification and production of differentiated cell lineages. Artificial reprogramming methods such as somatic nuclear transfer (SCNT), ES cell fusion-mediated reprogramming (FMR), and induced pluripotency (iPS) yield pluripotent cells that recapitulate many features of naturally pluripotent cells, including many of their epigenetic features. However, the route to pluripotent epigenomic states in artificial pluripotent cells differs drastically from that of their natural counterparts. Here, we compare and contrast the differing routes to pluripotency under natural and artificial conditions. In addition, we discuss the intrinsically metastable nature of the pluripotent epigenome and consider epigenetic aspects of reprogramming that may lead to incomplete or inaccurate reprogrammed states. Artificial methods of reprogramming hold immense promise for the development of autologous cell graft sources and for the development of cell culture models for human genetic disorders. However, the utility of artificially reprogrammed cells is highly dependent on the fidelity of the reprogramming process and it is therefore critically important to assess the epigenetic similarities between embryonic and induced pluripotent stem cells.
Introduction
Post-translational modifications (PTMs) of histones H3 and H4, substitution of canonical histones with variants, and cytosinemethylation of genomic DNA all participate in the epigenetic regulation of eukaryotic gene expression. Histone PTMs consisting of mono-, di-, and tri-methylation (me1, me2, me3) and acetylation (ac) are added to lysine (K) and arginine (R) residues located primarily in the N-terminal tails of histones, which protrude from the compact globular cores of nucleosomes. Constitutive heterochromatin contains abundant H3K9me2, H3K9me3, H3K79me3, and H4K20me, while conditionally silenced facultative heterochromatin contains H3K27me2, H3K27me3, H2BK5me3. Actively transcribed euchromatin contains H3K4me, H3K4me3, H3K9me, H3K27me, H3K79me, H3K79me2, H2BK5me, H3K9ac, H3K14ac, H4K5ac, H4K8ac H4K12ac and H4K16ac (Bernstein et al., 2002 , Eberharter and Becker, 2002 , Kubicek et al., 2006 . Most histone methylation is imposed by SET domain-containing histone methyltransferases, while removal of methyl marks is performed by Jumonji domain (Jmjd) containing histone demethylases (Takeuchi et al., 2006) . Acetylation usually facilitates transcription and is effected by histone acetyltransferases (HATs), while removal of acetyl groups is performed by histone deacetylases (HDACs). Modification states of specific lysine and arginine residues (by methylation or acetylation) directly influence transcriptional activity, and residuespecific methylation and acetylation states are regulated dynamically by the balance between histone methyltransferase/ demethylase and HAT/HDAC activities, respectively. Other PTMs include ubiquitination, sumoylation, and phosphorylation, and these often have functions other than transcriptional control. Strikingly, many of the enzymes required for the formation of specific PTMs are controlled by transcription factors tightly linked to the induction and maintenance of pluripotency, both in vitro and in utero. In addition, substitution of canonical histones with variants including but not limited to macroH2A, H1t, H1FOO, H3.3 (Ng and Gurdon, 2008a ) provides a further layer of molecularepigenetic complexity. This review illustrates how epigenetic and transcriptional mechanisms cooperate during normal reproductive biology and early development to produce toti-and pluripotent cells, and how similar pluripotent states are achieved via artificial reprogramming methods.
The genetic and epigenetic basis for pluripotency
Most notable among the genes expressed specifically in stem cells are the master pluripotency transcription factors Oct3/4/ Pou5F1 (Scholer et al., 1989a) , Sox2 (Avilion et al., 2003) , and Nanog (Chambers et al., 2003) . This set of master regulators controls the expression of downstream genes required for maintenance of pluripotency and repression of differentiation (Boyer et al., 2005; Li, 2010) . Oct4 is a universally required pluripotency factor, since pluripotent ICM cells cannot form in Oct4-/-mice (Nichols et al., 1998) . Furthermore, Oct4 expression levels are finely tuned and reduced or increased Oct4 expression induces differentiation to trophoectoderm and primitive endoderm lineages, respectively . Knockdown of Oct4 by RNAi causes more extensive changes in gene expression than knockdown of Sox2, Nanog or Rex1 (Grinnell and Bickenbach, 2007; Ivanova et al., 2006) , though these transcription factors are equally important in maintenance of pluripotency. Oct4 binds to the octamer consensus sequence ATGCAAAT and analysis of chromatin immunopreciptation (ChIP) data has identified more than 400 putative Oct4 target genes which also tend to recruit Sox2 and Nanog (Chavez et al., 2009; Li, 2010; Sharov et al., 2008) . Sox2, an HMG box domain protein, is regulated by Oct4 (Grinnell et al., 2007) and binds to its cognate promoters both by itself and in a complex with Oct4. Sox2, complexed with Oct4, binds to target promoters with bipartite POU/HMG regulatory elements that are typically separated by a three base-pair spacer. However, Sox2 can independently regulate Oct4 levels in embryonic stem cells (ESCs), and ESCs devoid of Sox2 differentiate into trophoectoderm-like structures similar to those observed in ESCs with reduced Oct4 expression. Nanog, a homeodomain transcription factor that binds to the TAAT(G/T)(G/T) motif represents the most notable target gene of the Oct4/Sox2 complex. It is required for maintenance of pluripotency (Yates and Chambers, 2005) and Nanog dimers confer cytokine-independent selfrenewal after overexpression in ESCs (Mullin et al., 2008) . Moreover, Nanog is also a critical regulator of cell fate decisions including the repression of primitive endoderm formation (Chambers et al., 2003) . In contrast to Oct4 deficiency, down-regulation of Nanog only predisposes ESCs for differentiation (Hyslop et al., 2005) and Nanog-/-ESCs can still self renew (Chambers et al., 2007) . Nanog regulation is complex and includes promoter regulation by Oct4 and Sox2, as well as FoxD3 and p53 and the growth factors LIF, BMP, and Wnts (Pan and Thomson, 2007) . Downstream targets of Nanog include the orphan nuclear receptor estrogen-related receptor beta (Esrrb), which in turn participates in an autoregulatory self-renewal feedback loop mediated through interactions of Esrrb with Oct4 and Sox2 (van den Berg et al., 2008) .
Several studies of the transcriptional pluripotency network controlled by the Oct4-Sox2-Nanog set (Boyer et al., 2005; Chavez et al., 2009; Loh et al., 2006; Matoba et al., 2006; Sharov et al., 2008) identified more than 1400 putative and confirmed target genes that can be subdivided into four broad groups ( Fig.  1 ): transcription factors, chromatin remodeling factors (including polycomb genes), cell cycle regulators, and suppressors of signaling. The Oct4-Sox2-Nanog triad mostly functions as a positive transcriptional regulator and only some 40 genes out of the 1400 are repressed by the triad complex. Many of the up-regulated genes are involved in the repression of transcription factors that can induce cellular differentiation (Fig. 1 ). In addition, some telomere-associated proteins including Terf 1, Terf 2 and RIF are also up-regulated by the pluripotency master regulators. Sall4, a recently discovered pluripotency factor , emerges as a factor equally critical to pluripotency since it shares the Oct4-Sox2-Nanog target gene set and also has been implicated in the control of Oct4 expression . We performed a meta-analysis of the combined data from these studies using gene-ontology (GO) classification for molecular function and identified a comprehensive collection of genes that is intrinsically linked to the organization of chromatin (Fig. 1 ). This gene collection includes the Jumonji domain containing histone H3K9 lysine demethylases 1A, 1C, and 2C, and the H3K4 demethylase Jarid1b. Remarkably, regulators for bivalent domain modification are also among the target genes and include Jarid2, Suz12, Cylp, and Aebp2. Suz12 encodes a core protein of the repressive polycomb repressive complex 2 (PRC2), whereas the latter two proteins interact peripherally with PRC2. JARID2 binds to more than 90% of PRC2 target genes and functions in the methylation of H3K27 (Pasini et al., 2008; Li et al., 2010) . Together with the positive regulation of the H3K4 methyltransferase SETD1B and the H3K9 specific methyltransferase EHMT1, this suggests that expression of the Oct4-Sox2-Nanog pluripotency triad alone may be sufficient to regulate enzymes necessary to establish bivalent domains in ESC chromatin. Further control over differentiation-associated gene expression is exerted through upregulation of the H3K9 methyltransferase SETD1B/KMT1E, which is especially required for repression of trophoectoderm specific gene expression (Lohmann et al., 2009) . Moreover, KMT1E also suppresses other lineage differentiation markers, many of which overlap with known targets for PRC2 mediated repression suggesting that KMT1E and PRC2 complexes control gene expression in concert. The Oct4-Sox2-Nanog triad also regulates histone methyltransferases with transcription-promoting functions including those imparting H3K4 methylation. Among these are chromodomain helicase DNA binding protein 7 (CHD7), which marks H3K4 methylation (Schnetz et al., 2009) , the CXXC finger protein Cfp1, which is required for targeting of the H3K4 methyltransferase SET1D1A (Tate et al., 2010) and the histone acetyltransferase MYST2, which is associated with transcriptionally active chromatin (Utley and Cote, 2003) . Together, this analysis demonstrates that pluripotent cells contain a rich and diverse epigenetic machinery and that their combined expression is controlled by the Oct4-Sox2-Nanog network alone.
The Oct4-Sox2-Nanog triad may also contribute to the higher basal levels of transcription observed in ESCs by positively regulating several RNA polymerase II (RNPII) associated factors (Chavez et al., 2009) . These may alter the RNPII core enzyme structure and confer increased polymerase initiation and elongation rates. The most prominent members of this group are Myosin VI (associated with enhanced RNP II transcription rates), the mediators of RNPII transcription Med12 and Med18, the elongation factors Ell and Tcea1, the TATA-box binding protein Taf12 and the general transcription factors GTF3C4, TCF4 and TFDP2 Fig. 1 . ES cell pluripotency network. The subset of target genes for Oct4, Sox2 and Nanog shown was selected from more than 1400 genes identified in five recent studies (Chavez et al., 2009; Matoba et al., 2006; Sharov et al., 2008; Loh et al., 2006; Boyer et al. 2005) . The selection was based on classification for function by gene-ontology (GO)-terms. Target genes in green boxes are up-regulated by the pluripotency factors whereas those in red are down-regulated. Solid lines indicate that all members within a subgroup regulate transcription in the same way whereas hatched lines indicate that subgroups contain members that either up-or downregulate transcription. (Chavez et al., 2009) . Oct4, Sox2 and Nanog also control microRNA expression, notably including those encoded by the miR-290-295 and 302 clusters, which together may regulate several hundred target messenger RNAs and counteract non-specific transcription through the microRNA controlled regulation of translation (Gunaratne, 2009) . Open chromatin and high rates of basal transcription may also contribute to the control of certain chromatin modifiers including H3K4-specific histone methyltransferases (Buratowski, 2009 ). This may occur through their association with phosphorylated serines 2 and 5 of the RNPII C-terminal domain (CTD), which facilitates targeting to specific genomic loci through binding of RNPII to promoter sequences and provides a feedback loop that reinforces the open chromatin conformation (Buratowski, 2009) . Moreover, this mechanism places the respective histone methyltransferases under the control of the Serine 2-and 5-specific cell cycle dependent kinases CDK 7 and 9, respectively, aiding in the marking with both transcription enhancing H3K4me and transcription repressing H3K27me marks. The affected genes form the group of so-called bivalent domain genes and encompass key regulators essential for cell fate decisions during embryogenesis (Bernstein et al., 2006) . They are bound by the polycomb repressive complexes 1 (PRC1) and 2 (PRC2), and in ESCs, nucleosomes linked to them contain the histone variant H2A.Z (Creyghton et al., 2008) . RNPII associates with bivalent domain genes in an elongation primed configuration but pauses at promoter-proximal sites due to the absence of Serine 2 phosphorylation and indirectly, PRC-mediated H2A ubiquitination (Brookes and Pombo, 2009) . Therefore, the regulation of RNPII-associated factors may aid in the formation of transcription complexes that are less repressive of gene expression.
Evidence exists indicating that lamin based nuclear organization counteracts pluripotency. ESCs contain a reduced content of heterochromatin and its structure is hyperdy-namic as evidenced by the short fluorescence recovery times after photobleaching of GFP-tagged nuclear proteins (Meshorer et al., 2006) . This may be due to the absence of A-type Lamins in ESCs (Constantinescu et al., 2006) , members of an intermediate filament family that are essential for the maintenance of the nuclear architecture. A-type lamins provide a regulatory scaffold for numerous activities at both the nuclear envelope and in the central nucleoplasm (Gotzmann and Foisner, 1999; Han et al., 2008b; Lloyd et al., 2002; Maraldi et al., 2008; Melcon et al., 2006; Prokocimer et al., 2009) . For example, lamins provide docking sites for H2 histones and, by virtue of the Barrier-to-Autointegration Function (BAF) protein, also to Histone H3 (Goldberg et al., 1999; Mattout et al., 2007; Montes de Oca et al., 2005) . These interactions, in addition to ones facilitated by other lamin binding proteins, are thought to play a fundamental role in the control of subnuclear heterochromatin localization (Gruenbaum et al., 2005) . Recent data show that A-type lamins associate with many transcription factors including SREBF1/F2, RB1, several SMAD proteins, the ING class of PHD finger proteins (Andres and Gonzalez, 2009; Worman, 2006) and new interactions with unidentified transcription factors are likely. Both, lamin-chromatin and lamintranscription factor associations result in the stabilization of DNAprotein interactions and provide a mechanism for lamin based control of RNA polymerase II transcription. Consistent with this hypothesis, ablation of A-type lamins in somatic cells is associated with a generalized upregulation of transcription (Parnaik, 2008) .
In ESCs, A-type lamins are up-regulated during the exit from pluripotency prior to the silencing of Oct4 (Constantinescu et al., 2006) . The absence of lamins in ESCs is thought to destabilize DNA-protein interactions, resulting in the observed continuous fluctuation of DNA-protein associations and low-level expression of large numbers of genes which contributes to pluripotency by enabling responses to greater numbers of environmental signals in ESCs.
In summary, the Oct4-Sox2-Nanog triad appears to be sufficient for the basal pluripotency feedback circuitry, control of the ES cell cycle, open chromatin organization, high basal ESC transcription rates and suppressive marking of key differentiation genes in bivalent chromatin domains. Upregulation of chromatin modifiers and numerous transcription factors play a large role in this process, which may be reinforced by the greatly decreased expression of lamin A/C in pluripotent stem cells.
Reprogramming during germ line maturation and gametogenesis
Expression of Oct4, Sox2 and Nanog is required for the formation of a new organism from a single cell but in somatic cells these factors are not expressed together. For instance, Oct4 appears in significant amounts only in the germ line and key pathways required for proper embryonic development may be epigenetically pre-coded during gametogenesis. After packaging with protamines, a small but significant fraction of canonical histones remain associated with the paternal genome, and they associate predominantly with genomic loci that are vital for embryogenesis including those encoding key embryonic transcription factors, signaling proteins and promoters of miRNAs (Hammoud et al., 2009b) . This striking finding suggests that some embryonic gene expression may be epigenetically pre-coded in the male germ line before fertilization. It also suggests a biphasic natural route to the reprogrammed epigenome consisting of a first phase of pre-patterning which occurs during gametogenesis and a second phase of active reprogramming which spans preimplantation development. Plausibly, during the first pre-patterning phase, the somatic epigenome may be subdivided into a fraction essential for post-fertilization development, one for post gastrulation-development and one containing genes that interfere with the formation of toti-and pluripotent cells (Carrell and Hammoud, 2010) . During preimplantation development, the second phase, the pronuclear epigenomes are reprogrammed to the totipotent state of the zygote and ensuing cleavages give rise to the pluripotent cells of the ICM (Fig. 2) . X chromosome reactivation and inactivation (XCR/XCI) for gene dosage compensation due to the presence of two sex chromosomes (Lyon, 1961 ) also occurs during gametogenesis and ensuing preimplantation development and represents one of the most prominent examples for natural reprogramming.
Resetting the somatic genome in primordial germ cells
Primordial germ cells (PGCs), the precursors of all germ cells, arise from the ICM in the proximal part of the epiblast shortly prior to gastrulation. PGC-specific changes in histone methylation occur as early as during the specification of the PGC fate, as evidenced by the PGC-specific expression of the transcription repressing histone methyltransferase Prdm1/Blimp1 (Tunyaplin et al., 2000; Turner et al., 1994) . Expression of this histone methyltransferase during PGC-genital ridge migration facilitates di-methylation of histones H2AR3 and H4R3 (Ancelin et al., 2006) , which may aid in maintaining PGCs in an undifferentiated state (John and Garrett-Sinha, 2009 ). The action of Blimp1 for PGC-specific gene silencing involves the recruitment of the Groucho-complex (Ren et al., 1999) and histone deacetylase activity to specific genomic loci (Yurke et al., 2000) including Hox genes (Ohinata et al., 2005) .
During maturation of PGCs to mature gametes, sequential epigenetic changes occur during the mitotic and meiotic cell divisions that distinguish the differentiated cells of the germ line from all other somatic cells. This cascade includes global changes in DNA and histone methylation, imprinting, and substitution of canonical histones with gamete-specific varieties (Godmann et al., 2009) . In mouse, PGCs arrive at the genital ridge in a globally DNA-hypomethylated state (Monk, 1987) and are then are rapidly remethylated (Hajkova et al., 2002) . Imprinted regions remain hypomethylated until day E13.5 (Lee et al., 2002) . The wave of gametic methylation peaks around E15.5 in the male mouse embryo, and is complete by birth (Fig. 2) . Mature gametes remain highly methylated until fertilization (Lees-Murdock and Walsh, 2008) . Consistent with the transcription enabling role of the H3K4 methylation, this mark remains excluded from genomic regions with high levels of DNA methylation (Tate et al., 2010) . Oogonia remain hypomethylated until maturation into oocytes (Lucifero et al., 2004; Obata et al., 2002) , whereas the spermatogonial DNA including retrotransposons (Monk, 1987) and imprinting control regions (ICRs) is already de novo methylated at the mitotically arrested prospermatogonial stage (Davis et al., 2000; Ueda et al., 2000) .
A recent gene expression study performed with both prospermatogonia and pachytene oogonia at E15.5 in mice identified several highly expressed constituents of the epigenetic machinery required for sequence-specific gene silencing (Lefevre and Mann, 2008) . These include the de novo DNA methyltransferase genes Dnmt3a, Dnmt3b, and the Dnmt3a activity enhancing Dnmt3l (Bourc'his and Bestor, 2004; Bourc'his et al., 2001; Chen and Riggs, 2005; Hata et al., 2002; Kaneda et al., 2004; Lehnertz et al., 2003; Webster et al., 2005) , as well as the maintenance DNA methyltransferase Dnmt1, albeit at lower expression levels. The CCXC finger 1 (PHD domain) gene Cxxc1/ Cfp1 represents one of the most strongly expressed genes in prospermatogonia and encodes a CpG binding protein (Tate et al., 2010) . Its spermatogonial function is unknown, but in ESCs, it is required for DNMT1-mediated maintenance of global DNA methylation (Carlone et al., 2005) but its function in spermatogonia requires additional investigation. Further chromatin modifiers present in prospermatogonia at significant levels include the H3K9 and K27 methyltransferases Ehmt1 and 2 (Eukaryotic histone methyltransferase and Eukaryotic histone lysine methyltransferase N 2/G9a) (Lefevre and Mann, 2008) . G9a interacts with Dnmt1 and both Dnmt3s, thereby stimulating their activities during prenatal testis development (Esteve et al., 2006) and aiding in the silencing of selected target sequences including Oct4 (Fig. 2) (Feldman et al., 2006) , retrotransposons and imprinting control regions (ICRs) (Mann et al., 2000; Racedo et al., 2009) . Two additional SET domain-containing histone methyltransferases, Ezh1 (enhancer of zeste homologue) and Setd1b (SET domain, bifurcated 1), are also up-regulated in progametogonia and contribute to sequence specific H3K9 and H3K27 methylation (Lefevre and Mann, 2008) . In concert with the increased levels of repressive histone marks during male germline development, several effectors of H3K9 and H3K27 methylation are also up-regulated in progametogonia including the chromodomain helicase DNA binding proteins Chd1l, Chd5 and the Tudor domain proteins Tdrd5 and 9, which also interact with H3K79 during DNA repair (Lefevre and Mann, 2008) . A number of histone demethylases are expressed at significant levels, including the H3K4 demethylase amine oxidase (flavin containing) domain 2 (Aof2) (Shi et al., 2004a) , the jumonji domain proteins Jarid2, Jarid1b, and the H3K9 demethylase Jmjd1a. Finally, in spermatogonia, the chromatin regulator Wdr45l, a WD-repeat containing protein required for conversion of H3K4me2 to the transcription promoting H3K4me3 mark (Dillon et al., 2005; Martin and Zhang, 2005 ) is also up-regulated, consistent with the high level of H3K4 methylation in these cells. Reestablishment of erased paternal imprints also occurs during male germ line development after biallelic expression in PGCs (Weaver et al., 2009) and is completed at the Fig. 2 . Epigenetic changes during natural reprogramming. Epigenetic profiles are represented qualitatively and were assembled from data published previously (Reik 2007; Chang et al., 2005; Zernicka-Goetz et al., 2009; Shi and Wu, 2009) . Hatched sections denote the absence of information regarding the expression status during this time.
time of birth (Szabo and Mann, 1995) . Imprinted loci frequently occur in clusters near imprinting control regions (ICRs) consisting of larger CpG islands (Ferguson-Smith and Surani, 2001; Reik and Walter, 2001 ), but only a small subset of all known ICRs are imprinted in the paternal germ line (Delaval and Feil, 2004) including the H19/IGF2/miR-675/miR-483 cluster (Peters and Robson, 2008; Thorvaldsen et al., 1998) , the Dlk1-Gtl2 cluster (Lin et al., 2003) and the Rasgrf1 locus (Yoon et al., 2002) . The explicit mechanism for prenatal imprinting is not fully understood, but requires DNA methyltransferase 3A (Dnmt3A) (Kaneda et al., 2004) and postnatal marking of paternal ICRs through additional histone modifications during chromatin condensation (Delaval et al., 2007) . Both imprinted loci and repetitive elements arising from retrotransposition (Whitelaw and Martin, 2001 ) are remethylated to prevent their transcription during gametogenesis. This process, which in mouse requires Dnmt3b, Dnmt3L and piwi-like proteins (Kuramochi-Miyagawa et al., 2008) , is required for successful completion of meiosis (Ollinger et al., 2010) .
Taken together, the above information demonstrates that epigenetic modulation is not only critical for germ line development and fertility, but may also have a previously underappreciated role in epigenetic pre-patterning for subsequent development after fertilization.
Spermatogenesis
During spermatogenesis all canonical DNA methyltransferases (Dmnts) are expressed and the spermatocyte DNA methylome resembles that of ES cells (Eckhardt et al., 2006; Farthing et al., 2008; Oakes et al., 2007) . DNA methylation increases significantly throughout spermatogenesis but numerous promoters with low-density CpG islands remain hypomethylated, including many of the Oct4, Sox2 and Nanog target genes (Farthing et al., 2008; Illingworth et al., 2008) . In contrast, the Oct4, Sox2 and Nanog genes themselves are methylated during spermiogenesis (Feldman et al., 2006) . Consistent with transcriptional silencing of the paternal genome during spermatogenesis, loss of the H3K4 demethylase Lsd1 (Katz et al., 2009; Shi et al., 2004b) causes germ cell apoptosis and sterility. Moreover, H3K9 and H3K27 methylation increases globally during meiosis, drop to an intermediate level and remain stable thereafter ( Fig. 2) (Payne and Braun, 2006) .
Further chromatin remodeling during spermatogenesis includes histone replacement in which a portion of canonical histones are substituted with testis-specific variants. An initial wave occurs immediately prior to meiosis yielding the replacement of the linker histone H1 with the variant H1t, H2B with tH2B, H2A with H2A.Z and H3 with H3.3. H1t is thought to aid in chromatin decondensation (Sarg et al., 2009) , tH2B may mark certain sperm maturation associated and ion channel genes, H2A.Z becomes enriched at pericentromeric regions (Hammoud et al., 2009a; Hammoud et al., 2009b) and H3.3, which has been demonstrated to mark transcribed genes Gurdon, 2008a, 2008b) , may aid in the transmission of chromatin states for genes that are functionally essential for spermatogenesis and/or preimplantation development. Once the final epigenetic marks have been established more than 80% to 95% of the canonical histones are replaced by protamines 1 and 2 (Tanphaichitr et al., 1978; Wykes and Krawetz, 2003) , which are required for maturation, fertility and extreme compaction of the paternal genome needed for packaging into the sperm head (Balhorn et al., 1988; Corzett et al., 2002) . The ratio of the two protamines determines the success of preimplantation development (PID), unexpectedly indicating that the sperm epigenome is essential to PID (DepaMartynow et al., 2007) . NURF301, an ISWI-containing chromatin remodeling complex catalyzing ATP-dependent nucleosome sliding and required for spermatogenesis, may aid in nucleosome arrangement in sperm (Kwon et al., 2009) .
The histones remaining in mature sperm chromatin often harbor H3K4 and K27 modifications and include all four canonical histones and the testis-specific tH2B variant (Gatewood et al., 1990; Kimmins and Sassone-Corsi, 2005) . Histone retention in sperm may mark the specific genomic regions for transcriptional regulation during PID. Consistent with this hypothesis, H3K4me2 and H3K4me3 marks are enriched at certain coding and noncoding loci. Among the non-coding loci are promoters of noncoding RNAs, miRNAs and imprinted loci (Hammoud et al., 2009a; Hammoud et al., 2009b) and among the coding loci are genes required for RNA metabolism, spermatogenesis, nuclear reorganization and, notably, embryonic transcription factors (Hammoud et al., 2009a; Hammoud et al., 2009b) . Many of the transcription factor genes also harbor the repressive H3K27 methylation mark (Bernstein et al., 2006; Hammoud et al., 2009a; Hammoud et al., 2009b; Ku et al., 2008) . Intriguingly, numerous genes affected by DNA and histone methylation changes are targets of Oct4, Sox2 or Nanog in ES cells and the expression of Oct4, Sox2 and Nanog alongside Sall4 is essential for spermatogenesis (Choi et al., 2007; Krentz et al., 2009; Pesce et al., 1998; Scholer et al., 1989b) . Their expression continues in the germ line until differentiation into gametogonia (Raverot et al., 2005) and both Oct4 and Nanog reappear postnatally in differentiated germ cells including spermatocytes and spermatids until puberty commences (Goel et al., 2008) . These results further corroborate the hypothesis that paternal epigenome pre-patterning may have an underappreciated role in directing expression of pluripotency associated genes in PID reprogramming (Reik, 2007) .
Pre-patterning of the maternal epigenome
Hypomethylated DNA is progressively remethylated during female PGC maturation, but this process may not involve Dnmt3L (Lucifero et al., 2007) . However, in comparison to its male counterpart, the DNA remains globally hypomethylated (Fig. 2) .
Histone methylation is also dynamically regulated during oogenesis. Levels of H3K4 methylation undergo stepwise increases during their maturation from day 10 post partum (pp), continue up to the germinal vesicle stage (GV-oocytes) (Kageyama et al., 2007) and are mostly paralleled by alterations in repressive H3K9 methylation (Fig. 2) . Maintenance of H3K4 and K9 marks likely requires an active mechanism, given the observed rapid histone H3/H3.3 and H3.3 exchange (Stewart et al., 2006) and H3K9 trimethylation in male pronuclei upon their transfer into enucleated GV-or MII-stage oocytes (Liu et al., 2004) . Histone acetylation and DNA methylation also increase during oocyte growth and closely parallel the changes in the H3K4 and K9 methylation levels, with the exception of GV-stage oocytes (Fig. 2) . The increased H3K4 methylation and histone acetylation levels stand in contrast to the observed transcriptional silencing in maturing oocytes but are apparently not associated with increased locusspecific transcriptional activity (De La Fuente et al., 2004) there-fore reflecting more global alterations in chromatin organization (Debey et al., 1993; Zuccotti et al., 1995) . One possibility is that the observed H3K4 methylation occurs at loci that are also H3K27 methylated, leading to the formation of bivalent domains (chromatin containing both H3K4me and H3K27me). To date, we are unaware of any studies addressing the existence of bivalent domains in oocytes.
Substitution of canonical histones also occurs in the female germ line and includes the oocyte specific histone variant H1foo. H1foo remains present in the ovum (Chang et al., 2005; Clarke et al., 1997; Tanaka et al., 2001) where it localizes primarily to the perinucleolar heterochromatin. Its ablation causes failure to extrude the first polar body, indicating that it is essential for oocyte maturation (Furuya et al., 2007) though its exact role is currently unknown.
X chromosome reactivation (XCR) represents a major chromatin remodeling event and occurs in PGCs as early as E8.5. Once PGCs colonize the genital ridges (E10.5), the majority of them contain two active X chromosomes (Xa) as indicated by the absence of Xist RNA, a marker for the inactive X chromosome (Xi; see below) (McLaren, 2003) . However, XCR occurs stochastically, and XCR is still incomplete at E14.5 indicating a gradual process (Sugimoto and Abe, 2007) , which may be analyzed more effectively in forthcoming vitro models for gametogenesis (Aflatoonian et al., 2009 ).
Reprogramming and preimplantation development (PID)
Progression to the second phase of natural epigenetic reprogramming commences with fertilization. The fertilization event triggers a series of Ca2+ oscillations that activate the egg, inducing completion of meiosis II and extrusion of the second polar body. The oscillation ends with the subsequent decondensation of paternal and maternal chromosomes and the formation of the male and female pronuclei (reviewed in (Swann et al., 2006) ). Zygotic genome activation (ZGA) commences during this time and occurs as maternal stores of RNA and protein are degraded.
Soon after protamine removal and decondensation, the paternal DNA becomes demethylated, a condition that persists until the morula stage (Santos et al., 2002) . Demethylation of the paternal genome occurs rapidly even in the absence of replication Oswald et al., 2000) and in mouse, rat, pig and cattle zygotes, but at the 16-cell stage in rabbit (Shi et al., 2004a) . The mechanism for pronuclear DNA demethylation has not been identified, but candidate proteins include the DNA excision repair enzymes (Mendez-Acuna et al., 2010) . Pronuclear DNA demethylation appears to represent the default pathway and protection from demethylation requires the maternal factor Stella /Pgc7. Further zygotic demethylation is likely the result of passive demethylation caused by DNA replication without access to the maintenance DNA methyltransferase Dnmt1 (Rougier et al., 1998) , even though Dnmt1 protein is constitutively expressed (Cirio et al., 2008; Kurihara et al., 2008) . Subtle differences exist for Dnmt1o expression in males and females which is active only during the eight cell stage after nuclear import. Female embryos contain the isoform whereas in male embryos alternative splicing prevents its translation, a situation which may account for the differences in maintenance of imprinted loci in male and female embryos (Cirio et al., 2008) . Remethylation commences at the transition from morula to blastocyst but global DNA methylation levels may not be mechanistically critical; in mouse the extent of DNA methylation in the ICM exceeds that of the trophoectoderm (Santos et al., 2002) whereas in humans the opposite is observed (Fulka et al., 2004) .
During sperm chromatin decondensation, substitution of protamines with canonical and variant histones is a prerequisite for subsequent demethylation and transcriptional activity of the male pronucleus (McLay and Clarke, 2003) . The transcription-promoting histone variant 3.3 (Ahmad and Henikoff, 2002; Chow et al., 2005) is incorporated solely into the male pronucleus at the time of protamine substitution and remains enriched in the paternal chromatin for several cell divisions (Torres-Padilla et al., 2006; van der Heijden et al., 2005) . This may aid in the transfer of the epigenetic code stored in the prepatterned male epigenome to the zygotic progeny during mitosis (Chow et al., 2005) . In the maternal pronucleus, the unique histones H1foo and macroH2A are down-regulated only after the first mitotic division (Chang et al., 2005) . MacroH2A remains repressed until the morula stage and associates with the PRC2 complex (Buschbeck et al., 2009) , indicating that its expression may be associated with gene silencing (Chang et al., 2005) .
Several oocyte-derived proteins are critical for remodeling of sperm chromatin which coincides with the so-called minor phase of zygotic gene activation (Fig. 2) including nucleoplasmin 2, basonuclin, the transcription intermediate factor 1 (Tif1) and the chromatin factor Brg1 (Minami et al., 2007; Sun et al., 2007; Torres-Padilla et al., 2006; Zernicka-Goetz et al., 2009 ). Nucleoplasmin 2 is required for protamine exchange and basonuclin stimulates RNPI and II transcription. Brg1/Smarca4 and Smarcc1/Baf155, subunits of the nucleosome remodeling complex Smarca5/Iswi/Snf2h, appear enriched in the male pronucleus (Aoki et al., 1997) and are critical for maintenance of H3K4me2 levels. Tif1a modulates expression of several genes in the zygote and is required for targeting of RNPII, Snf2 and Brg1. The composition of the ensuing new paternal epigenome remains strikingly distinct from its maternal counterpart. It is enriched in transcription promoting histone modifications and uniquely contains H3K4me and H4K20me (Kourmouli et al., 2004; van der Heijden et al., 2005) . The preferential association of some of the maternally provided factors with the paternal genome may provide the critical link to the observed asymmetry between the parental epigenomes and form the molecular basis for the higher transcription rates from the paternal genome (Eberharter and Becker, 2002) . Amplifying the effect of ooplasmic factors, which may ultimately account for the exclusive appearance of H3K4me in the paternal epigenome shortly after fertilization, is the presence of sperm derived H4K8ac and H4K12ac (Lepikhov and Walter, 2004; van der Heijden et al., 2006) . H3K4me3 marks appear 8-10 hrs post-fertilization in mouse and parallel the de novo methylation of H3K9 which remains restricted to the monomethylated form in the paternal epigenome (van der Heijden et al., 2005) . The appearance of these marks is accompanied by subsequent histone acetylation at residues H3K9, H3K14, H3K18, H4K5, H4K12 and H4K16 and by maintenance of paternal pronuclear H3K9 hypomethylation. The observed histone acetylation results from either substitution or acetylation of freshly incorporated histones by ovum-derived residual meiosis specific matura-tion factors (van der Heijden et al., 2006) . The block of the ooplasmic H3K9 methylase (Liu et al., 2004 ) may be facilitated either by the H3K9me3 specific histone demethylase Jmjd2a (Katoh and Katoh, 2007) and/or through potential masking of paternal pronuclear H3K9me through loose association with the heterochromatin protein 1 (HP1) (Santos et al., 2005) .
Similarly and consistent with the heightened transcriptional activity in the paternal pronucleus, the paternal epigenome is hypomethylated at the H3K27 residue in the pronuclear stage (Erhardt et al., 2003b) . However, it is unknown whether epigenetically prepatterned loci in the male pronucleus, which include HOX gene clusters, non-coding RNAs, paternally expressed imprinted loci and ES cell specific bivalent domain promoters (Hammoud et al., 2009b) , are exempt from histone substitution. Further investigation of this issue is required to confirm the attractive hypothesis that exemption from substitution maintains their predisposition to gene expression at critical time points during development and prevents their activation outside of the required temporal sequence during embryogenesis.
The maternal pronuclear genome is less transcriptionally active (Adenot et al., 1997) , its epigenome is hypoacetylated and it contains high levels of repressive H3K9me2 and H3K9me3 (Minami et al., 2007) . Nevertheless, significant levels of the transcription enhancing H3K4me3 are present. Curiously, only maternal pronuclei contain the histone modifications H3K64me and H4K20me3 in zygotes. H4K20me3 is associated with constitutive heterochromatin including centromeric, pseudoautosomal and some telomeric regions (Kourmouli et al., 2004) . In the zygote, trimethylation of H4K20, typically performed by the histone methyltransferase Suv420h1 and h2 appears to depend on Suv39h, an H3K9-specific methyltransferase, providing a link between H3K9 and H4K20 trimethylation (Kourmouli et al., 2004; Puschendorf et al., 2008) . Levels of H4K20me3 are reduced during the first mitotic division and remain fixed until the blastocyst stage (Kourmouli et al., 2004; van der Heijden et al., 2005) and, in conjunction with the paternal H3K4me, provide a mechanism by which the parental genomes can be distinguished. The role of trimethylated H3K64 is less well understood, but its reappearance is linked to blastocyst implantation (Daujat et al., 2009) .
Completion of pronuclear restructuring culminates in major zygotic genome activation (ZGA) and completion of maternal RNA degradation (Schier, 2007; Schultz, 2002) , which in mouse is paralleled by commencement of the first embryonic cell division. Species-specific differences in timing exist and indicate the requirement for completion of pronuclear chromatin reorganization into a state compatible with the ensuing totipotent transcriptome (Telford et al., 1990) . This may also include the degradation of Atype lamins, supplied by the ovum and present in the early zygotic stage. Its degradation time course may represent one determinant for onset of ZGA. Support for this hypothesis stems from the observation that A-type lamin expression remains repressed until gastrulation (Foster et al., 2007; Hall et al., 2005; Houliston et al., 1988; Schatten et al., 1985) . During ZGA, all circuitry essential for toti/pluripotency is up-regulated including the expression of Oct4, Sox2, Nanog and Sall4 which persists until the late blastula. The major ZGA is completed at the four-cell stage and while blastomeres at this stage contain equal levels of methylated histones their association with specific loci in different blastomeres has not yet been determined. Methylation of H3R17 and R26 is essential for the formation of totipotent blastomeres at least up to the fourcell stage since high levels of this epigenetic mark are required for the expression of pluripotency genes . Down regulation of the associated arginine-methylase coactivator associated methyltransferease 1 (Carm1) induces loss of pluripotency gene expression including Nanog and Sox2, resulting in subsequent differentiation, linking this enzyme mechanistically to the maintenance of pluripotency (Torres-Padilla et al., 2007; ).
The first cell fate decision is initiated after transition from the four-cell stage to the eight-cell stage and during the progression into the 32-cell stage (Pedersen et al., 1986) . During this time, localization of the individual blastomeres permits the distinction of inner and outer blastomeres and this spatial difference is likely to contribute to the observed divergent gene expression (Jedrusik et al., 2008) . The Tead (Nishioka et al., 2008; Yagi et al., 2007) , Elf5, Cdx2 and Eomes genes (Niwa et al., 2005; Russ et al., 2000; Strumpf et al., 2005) become successively activated in the outer blastomeres and specify their trophoectoderm fate by repressing Oct4, Sox2 and Nanog, which remain expressed in the inner pluripotent blastomeres (Avilion et al., 2003; Chambers, 2004; Chambers et al., 2003; Chambers and Tomlinson, 2009; Mitsui et al., 2003; Nichols et al., 1998; Scholer et al., 1989b; Silva et al., 2009) . Accordingly, all Oct4, Sox2, Nanog and Sall4 promoters contain euchromatin marks, i.e. trimethylated H3K4, acetylated H4K16 and absence of methyl-cytosine. Although global histone methylation patterns in different blastomeres diverge from each other once the first cell fate decision occurs, all inner blastomeres remain pluripotent, indicating that the lack of polarity predisposes these cells for maintenance of pluripotency up to the ICM stage . Sustained Oct4 expression in the inner morula cells causes Cdx2 and Tcfcap2 silencing through Oct4 mediated targeting of H3K9me3 to the respective genomic loci (Yuan et al., 2009) . Most epigenetic alterations during this time target the silencing of differentiation associated genes, and PRC2 associated proteins play a significant role in this process. Their reduction leads to severe growth retardation in neonates, possibly due to dysregulation of the murine H19/Igf2 locus (Erhardt et al., 2003a) and impaired Oct4 silencing . In addition, PRC1/2 mediated repression precedes Suv39h silencing during early embryogenesis at selected genomic loci since mouse embryos with reduced levels of the PRC2 associated histone methyltransferase Ezh2/Kmt6 also show reduced levels of the repressive H3K9me3 mark (Erhardt et al., 2003b) . Therefore, both Eset/Kmt1e and Ezh2/Kmt6 are essential for derivation of pluripotent stem cells (Dodge et al., 2004; O'Carroll et al., 2001) .
Epigenetic reprogramming is completed in the final stages of PID with X chromosome inactivation (XCI). XCI is marked by the interplay of histone modifications, expression of non-coding RNAs, and DNA methylation for transcriptional regulation. XCI is controlled by X chromosome elements at the X inactivation center (Xic). Xic functions both in trans, through transient pairing of the two X chromosomes that marks the onset of XCI (Xu et al., 2006) , and in cis through the non-coding RNAs Xite, Tsix, and Xist located within it. Allele-specific upregulation of Xist on the future inactive X chromosome (Xi) is preceded by the down-regulation of the antisense transcript Tsix and the enhancer-like Xite (Ogawa and Lee, 2003; Stavropoulos et al., 2005) . Xist coats the future Xi, initiating a cascade of epigenetic events that result in transcriptional silencing of the future Xi along its entire length. These epigenetic modifications include a set of repressive histone modifications, acquisition of the histone variant macroH2A, and DNA methylation at CpG residues (Lucchesi et al., 2005) and also facilitate the continued maintenance of Xi silencing in somatic cells. Reactivation of the Xi in the germ line requires the presence of hitherto unknown reprogramming factors that are also present in the fertilized zygote.
Artificial reprogramming
Three different methods have been established for the artificial reprogramming of somatic cells (Fig. 3) including somatic cell nuclear transfer (SCNT) into enucleated oocytes, fusion mediated reprogramming (FMR) and transcription factor mediated induction of pluripotency (iPS).
Somatic cell nuclear transfer
Mature vertebrate oocytes have the ability to reprogram the genetic content of somatic cells to a state of totipotency. SCNT was first demonstrated in Xenopus (Gurdon, 1962) . Only after considerable time was SCNT achieved in sheep (Campbell et al., 1996; Wilmut et al., 1997) , and then successes were rapidly reported for mice (Wakayama et al., 1998) . To date, SCNT remains the only method of artificial reprogramming that is capable of yielding a state of totipotency, as reconstructed embryos produced by this method can develop into mature blastocysts in vitro, which upon implantation yield all extra-embryonic cellular lineages in addition to the embryo proper. The source of biochemical activities that facilitate reprogramming are contained within the ooplasm of mature oocytes that are arrested at Meiosis II (MII), which have been made devoid of genetic material. Because MII oocytes are arrested in meiotic metaphase, they lack nuclear envelopes and their ooplasm is thus a mixture of nucleoplasmic and cytoplasmic components. Following transfer of the somatic nucleus into recipient oocytes, the somatic nucleus rapidly disassembles, and the chromosomes condense and form a disorganized spindle containing a 2N complement of somatic chromosomes. Then, upon activation and suppression of polar body extrusions to maintain a diploid content of chromosomes, the reconstructed embryos execute the remainder of preimplantation development much like embryos produced by normal fertilization. Somatic nuclei contain differentiated transcriptional and epigenomic states that are imposed by their somatic cell type. The epigenome and transcriptome states of somatic nuclei are readily undone during the presumably massive reprogramming that occurs shortly after SCNT. By inference, MII ooplasm must therefore contain a highly effective machinery that can establish a state of totipotency upon somatic chromosomes. Since SCNT occurs within single cells, the paucity of material in this system makes cell biological investigations especially attractive. One of the most established epigenetic features of normal female diploid somatic cells is X chromosome inactivation. Analysis of the inactive X chromosome during SCNT reveals that X chromosome inactivation can be reversed during this process in the embryo proper. However, the inactive X chromosome of somatic cell origin is retained in a uni-parental imprinted-like state in trophectodermal lineages of SCNT embryos (Eggan et al., 2000) . X chromosome inactivation, and even maintenance of proper ploidy, is less stringent in SCNT embryos as compared to normal embryos (Nolen et al., 2005) , a finding that is in agreement with greatly reduced rates of development to term of SCNT embryos as compared to normal fetal development. The extent to which reduced rates of fetal development can be attributed to faults in epigenetic reprogramming cannot easily be ascertained, but analyses of X inactivation suggest that incomplete epigenetic reprogramming plays a major role.
A number of studies show that the degree and fidelity of epigenetic reprogramming is variable in SCNT. Indeed, many studies indicate the partial or improper epigenetic reprogramming is associated with developmental failure of SCNT embryos. For instance, expression of imprinted genes is abnormal in most blastocysts created by SCNT (Mann et al., 2003) . Some of the failures in reprogramming during SCNT can be attributed to epigenetic memory of somatic cell transcription states, as in the case of the endoderm-specific endodermin (edd) or the mesoderm specific MyoD genes which continue to be transcribed when endoderm and mesoderm cells, respectively, are used as nuclear donors. The MyoD gene is transcribed in reconstructed embryos for many cell divisions, and the MyoD promoter remains associated with histone H3.3, a variant that is incorporated into actively transcribed genes (Ng and Gurdon, 2008b) . Epigenetic memory of somatic chromatin states has also been reported in bovine SCNT embryos, which retain H3K9me marks and DNA CpG methylation marks that resemble those of the somatic cell donor type (Santos et al., 2003) . Developmentally regulated genes (including Hox genes) are precociously marked in ES cells and ICM cells by bivalent domains, consisting of the combined occurrence of H3K4me3 and H3K27me3. Bivalent domains are later resolved during ensuing development, where they retain only H3K4me3 (if expressed) and H3K27 only (if silenced) (reviewed in (Rasmussen, 2008) ). However, in SCNT embryos, bivalent domains are perturbed, and SCNT embryos in general have higher expression of bivalent genes. Furthermore, this effect is associated with mis-regulated levels of PRC2, a finding that suggests that failed bivalent domain epigenetic regulation may be a key cause for post-implantation failure of SCNT embryos (Esteban et al., 2010) . In general, many blastocysts are produced during in vitro development of SCNT embryos to the blastocyst stage. However, after implantation and subsequent embryogenesis in vivo, a high proportion of SCNT embryos die, probably because it is the rare SCNT embryo that has been sufficiently reprogrammed to develop to term.
ES cell fusion-mediated reprogramming (FMR)
Embryonic germ (EG) cells are derived from primordial germ cells (PGCs) and can reprogram somatic cells on an epigenetic level when EG cells are fused to somatic cells such as thymic lymphocytes (Tada et al., 1997) . In such EG/somatic hybrids, demethylation of imprinted genes was observed, resulting in a hypomethylated state of the normally imprinted Peg1/Mest gene in the hybrids, a state normally observed only in germ cells. Subsequently, it was found that ES cells also harbor activities that can reprogram the somatic genome to a state of pluripotency upon fusion (Tada et al., 2003) . The resulting hybrid lines, though roughly tetraploid, exhibit pluripotency reminiscent of ES cells. Successful reprogramming results were also obtained by fusing human ES cells with human fibroblasts (Cowan et al., 2005) . In another study, the transcriptome of mouse ES cell/fibroblast hybrid lines was found to be very similar to normal ES cells and the use of expressed polymorphisms confirmed that genes residing on chromosomes of fibroblast origin assumed a transcriptional state resembling that of ES cells (Ambrosi et al., 2007) . Interestingly, the reprogramming activities within ES cells are confined to the nucleus since karyoplasts, but not cytoplasts, can achieve FMR (Do and Scholer, 2004) . The above studies show that ES/somatic cell hybrid cell lines are pluripotent, and have gene expression states similar to normal ES cells. FMR occurs quickly as compared to iPS, being essentially complete after only one cell cycle, with demethylation of Oct4 proximal enhancer element (Han et al., 2008a) . Methylation analyses of pluripotency genes have also been conducted in hybrid cells produced by fusion of Mus musculus ES cells and Mus caroli splenocytes. In these hybrid cells, CpG sites near Oct4 and Nanog on the caroli supplied chromosomes became substantially demethylated in the reprogrammed hybrids (Battulin et al., 2009) . The mechanism responsible for FMR also involves the ability of cells to remodel their histone modification content. In a recent study, using fluorescent reporters to indicate fusion and the establishment of pluripotency, it was found that knockdown of histone methyltransferase G9a promoted reprogramming. Furthermore, overexpression of the histone demethylase Jhdm2a causes increased reprogramming effectiveness as judged by Oct4 promoter-driven GFP expression . Together, the results indicate that FMR is associated with changes in the modification states of histones, and decreased CpG cytosine methylation near promoters of key pluripotency genes.
Activation of the inactive X chromosome has also been reported in the experiments that employ reprogramming mediated by fusion of female somatic cells with pluripotent counterparts. Initial attempts to reprogram somatic Xi in female fibroblasts by fusion with murine teratocarcinoma stem cell lines failed (Graves and Young, 1982) . Further fusion attempts of murine embryonal carcinoma (EC) cells with female lymphocytes led to the classification of EC cells into two groups, one with and one without the potential to reactivate the Xi of the somatic origin in EC-like hybrids (Mise et al., 1996) . These results most likely reflect the developmental stages from which these EC cells have been derived, as certain EC-like hybrids show complete reactivation of X chromosomes, with subsequent random XCI of any three out of four X chromosomes present in fusion cells (Takagi, 1993) . On the other hand, fusion experiments in which ESCs were used as fusion partner that will bring about reprogramming capabilities, show more consistent and complete reactivation of the Xi from the somatic partner. Hybrids created by fusion of male murine ESCs with female mouse splenocytes showed presence of synchronously replicating X chromosomes, as judged by BrdU incorpora-tion, followed by colchicine treatment and Giemsa staining (Matveeva et al., 1998) . Synchronously and early replicating X chromosomes have also been observed in the fusions between male ESCs and adult thymocytes (Tada et al., 2001) . This report further showed punctuate Xist RNA-FISH signal on three X chromosomes present in hybrid cells, indicative of all three X chromosomes being in pre-inactivation state.
iPS -Conceptual basis for factor based reprogramming
Reprogramming of the somatic genome to a state of pluripotency by introduction of defined factors has recently been reported (Takahashi and Yamanaka, 2006; Yu et al., 2007.) . The success of iPS, which can be initiated by only four (or fewer) factors, shows that terminally differentiated cells have the capacity to reorganize their epigenomes dramatically, if only the correct cues are given. Conceptually, these cues represent the key mediators of epigenetic remodeling and a set of master transcription factors active during natural reprogramming in PID. In addition, a series of molecular events resembling those in gametogenic prepatterning may also need to occur. This may require the expression of additional effectors expressed during gametogenesis for high efficiency artificial reprogramming.
Methods for generation of induced pluripotent stem cells
Historically, iPS cells have been generated by introduction of either Oct4, Sox2, Klf4 and c-myc or Oct4, Sox2, Nanog and Lin28 (Fig. 4) (Brambrink et al., 2008; Stadtfeld et al., 2008; . More recently, doxycycline-controlled lentiviral delivery systems have been generated in which the reprogramming factors are expressed from a single cistron linked through multiple 2A ribosome skipping sequences (Shao et al., 2009) . A significant effort has been expended to omit viral integration by the use of loxP sites introduced into the viral LTRs for near complete removal of the viral cassette through expression of Crerecombinase (Soldner et al., 2009) . Alternatively, single cistron expression cassettes encoding the four reprogramming factors have been delivered into cells through piggyBac transposons which avoid any remaining integration through expression of transposase or Cre-recombinase (Kaji et al., 2009; Woltjen et al., 2009) . Finally, adenovirus based vectors with inherent low integration frequencies have also successfully been used for iPS from both mouse and human fibroblasts (Stadtfeld et al., 2008; Zhou and Freed, 2009 ). Unfortunately, adenoviral based gene expression suffers from low infectivity and reprogramming rates as low as of 0.0002% in man, even if much higher amounts of virus and multiple rounds of infection are employed (Stadtfeld et al., 2008; Zhou and Freed, 2009) .
Cell membrane penetrating protein technology has also been utilized successfully for the introduction reprogramming factors into somatic cells using C-terminal fusions selected reprogramming factor, the TAT protein transduction domain and a nuclear localization signal (Bosnali and Edenhofer, 2008) . Alternatively, into somatic cells (Takahashi and Yamanaka, 2006; Yu et al., 2007) . Currently, numerous approaches are available for the reprogramming of somatic cells ranging from introduction of additional factors to numerous viral and nonviral gene transfer strategies. Other variations include choice of somatic cells, the levels and time course of factor expression, culture conditions, and methods to identify bona fide iPS cells and to some extent these protocols reflect the method chosen for factor delivery (Takahashi et al., 2007; .
Most technical alterations target disadvantages inherent to retroviral gene transfer methods since retroviruses only infect dividing cells, integrate into the host genome thereby giving rise to genomic mutations and tend to be gradually silenced even if reprogramming is incomplete. The latter is of particular concern since transgene silencing differs from cell type to cell type and is most efficient in ES cells (Ma et al., 2003) . Moreover, reactivation of the transgenes could also be observed . Lentiviruses escape many of these issues and have been used successfully for the derivation of iPS cells (Yu et al., 2007) . One significant modification in the use of lentiviral vectors consists in the use of a doxycycline-inducible construct, permitting precise control over transgene expression substitution of TAT sequence with oligo-arginine has also been reported (Yang et al., 2009 ) but either approach has yet to demonstrate efficiency in producing iPSCs. In a variation of this approach, mouse ES cell extracts were introduced into streptolysin O-mediated reversible permeabilized cells and bona fide iPS cells were successfully derived (Cho et al., 2010; Collas and Taranger, 2006) .
Finally, small molecules have also been employed for reprogramming with various success, but no iPS cell lines have been created yet using this approach alone . However, supplementation of reprogramming factors and even substitution of individual factors with small molecules has been demonstrated to drastically increase the efficiency of reprogramming. Components used include HDAC inhibitors such as valproic acid, suberoylanilide hydroxamic acid and trichostatin A, DNA methyltransferase inhibitors such as 5'-azacytidine (5'-azaC) and RG108, histone methyltransferase inhibitors such as BIX01294 and Ca-channel activators such as R(+)Bay K 8644 (Huangfu et al., 2008a; Shi et al., 2008) . Addition of valproic acid, which is also beneficial in SCNT (Huangfu et al., 2008a) , increased reprogramming efficiency 100-fold and allowed for successful reprogramming to occur without the addition of factors Klf4 and c-myc, two known oncogenes (Huangfu et al., 2008b) . Intriguingly, partially reprogrammed cells obtained during reprogramming show significant hypermethylation of important pluripotency-related genes and addition of 5'-aza-cytidine ameliorated hypermethylation without affecting the silencing of the viral transgenes (Huangfu et al., 2008a; Mikkelsen et al., 2008) , albeit high levels of cell death were observed .
Remarkably, choice of somatic cell equally affects reprogramming efficiency. Both diminished proliferative and increased senescent status affect reprogramming rates negatively (Banito et al., 2009 ). In addition, continued passaging in vitro also decreases reprogramming rates Utikal et al., 2009) due to an increase in uncontrolled somatic cell DNA damage. Subsequent increase in p53 activity induces apoptosis upon viral entry and prevents reprogramming (Marion et al., 2009) . Consistent with this observation, p53 deficient cells can be fully reprogrammed despite DNA damage (Marion et al., 2009; Utikal et al., 2009) and several approaches have been employed that affect the p53 signaling pathway including p53-knock down (Hong et al., 2009; Kawamura et al., 2009; Marion et al., 2009; Utikal et al., 2009) , p21 knockdown and Ink4/Arf inactivation (Banito et al., 2009; Hanna et al., 2009; Hong et al., 2009; Kawamura et al., 2009; Li et al., 2009) .
Reprogramming mechanism and defects
The epigenetic mechanism underlying factor based artificial somatic reprogramming remains largely enigmatic. The emerging variety of reprogramming strategies suggests that artificial reprogramming occurs in a random sequence of chromatin modifying events in all cells expressing the entire set of reprogramming factors. A viable order of events occurs only in a few random cells and successfully yields ESC-like cells (Yamanaka, 2009 ). This stochastic model contrasts the less likely hypothesis that successful reprogramming occurs only in cells that preexist in a reprogramming permissive state and employs an orchestrated sequence of events akin those during natural reprogramming in the germ line and PID (elite model). However, similarities between a zygote and pluripotency factor expressing somatic cells exist and certain elements of the natural reprogramming are recapitulated during the production of induced pluripotent stem cells including the upregulation of the Oct4, Sox2 and Nanog dependent pluripotency network. It should be noted in this context that artificial upregulation of Oct4 and Sox2 alone is sufficient for induction of Nanog, obviating the addition of exogenous Nanog (Jaenisch and Young, 2008) .
In comparison to Oct4 and Sox2, Klf4 and c-Myc appear to exert less specific and more pleiotropic functions. For instance, the somatic chromatin is far less dynamic than its pluripotent counterpart (Meshorer et al., 2006) and is likely to obstruct access for Oct4 and Sox2 to their native genes. C-myc may function as a general transcriptional activator and chromatinopener (Knoepfler et al., 2006) given its association with p300, CREBP and TRRAP, all components of histone acetyltransferase complexes including STAGA and TIP60 (Faiola et al., 2005; Liu et al., 2008; Park et al., 2001; Vervoorts et al., 2003) . More specifically, c-Myc may also be required for activation of one of its target genes encoding telomerase reverse transcriptase required for sustained proliferation of iPS cells (Liu et al., 2008) . Indeed, inclusion of TERT into the reprogramming mix is associated with increased reprogramming efficiencies (Park et al., 2008) . Further targets include the cell-cycle associated genes p15, p21 and cyclin E. Together with c-Myc induced enhanced replication dependent DNA-synthesis, their regulation may precipitate the cell cycle shortening observed in pluripotent stem cells (Egli et al., 2008) , aiding in the increased frequency of opportunities for epigenetic reprogramming (Scheper and Copray, 2009 ). Intriguingly, Oct4 and Sox2 are only able to activate the ES-cell specific gene LEFTY1 in the presence of Klf4 (Nakatake et al., 2006) . In addition to aiding Oct4 and Sox2 in gene activation, Klf4 inhibits p53 which may be important for activation of the Nanog gene in senescent cells (Lin et al., 2005; Rowland et al., 2005) .
Consistent with the comprehensive effects of the core reprogramming factor mix, a number of additional factors have been identified that are capable of either substituting Klf4 or c-myc or further supplement this quartet. Prominent examples for these proteins are Lin28 (Viswanathan et al., 2008 ), Esrrb (Feng et al., 2009 or Sall4 . Lin28 interferes with differentiation through RNA stabilization, Esrrb mediates a key pathway downstream of the master pluripotency regulators and Sall4 affects the regulation of Oct4 directly .
During the generation of iPS cells, both incompletely and fully reprogrammed cells are obtained, but fully reprogrammed pluripotent stem cells appear at much lower frequencies than in SCNT or FMR, likely owing to the inability to control expression levels during induced expression of reprogramming factors. For instance, both expression of Oct4 below and above a predetermined threshold are known to induce differentiation into either trophoectoderm and primitive endoderm or mesoderm, respectively (Gidekel et al., 2003; Niwa et al., 2000; Zaehres et al., 2005) . Similarly, imbalance of Klf4 and c-Myc expression affects reprogramming integrity significantly, since Klf4 is thought to balance c-Myc via control of p21 activity (Rowland and Peeper, 2006; Yamanaka, 2007) . The effect of factor imbalance is exemplified by employing direct transfection of repro-gramming factor, encoding modified RNAs in defined amounts which increases iPS efficiency almost 100 fold (Warren et al., 2010) . Further interdependencies including the senescent state and genomic integrity of the target cells are just beginning to emerge (Banito et al., 2009) . Consistent with the complexity and probabilistic nature of artificial reprogramming, most of the colony-forming cells demonstrate a partial reprogrammed phenotype as judged by above criteria and only a small number genuine iPS cells remain.
Consistent with the low frequency for bona fide iPS cells is the scarcity with which viable transgenic adult mice can be generated through either chimera formation or tetraploid complementation (Boland et al., 2009; Zhao et al., 2009) . Furthermore, recent reports employing in depth molecular analyses suggest that the successful generation of iPS cells as measured by morphological criteria, molecular marker expression (Tra1-60/ 1-81, SSEA1/mouse, SSEA3/human, Nanog and Oct4 (Brambrink et al., 2008) ), promoter methylation status and the ability to give rise to numerous types of differentiated progeny during teratoma formation, may overestimate the number of bona fide iPS cells generated. For instance, the typically performed analysis of DNA methylation patterns for the Oct4 and Nanog promoters reveals small but detectable differences between ES cells and iPS cells (Maherali et al., 2007; Okita et al., 2007; Smith et al., 2009; Takahashi and Yamanaka, 2006; Wernig et al., 2007) , indicating a sometimes minute change in the overall density of methylation marks (Boyes and Bird, 1992; Smith et al., 2009) . This might affect endogenously produced Oct4 levels and the extent of downstream reprogramming since Oct4 levels are greatly tuned for maintenance of pluripotency . Examples illustrating the effect of near-miss of complete reprogramming include similarity but not identity in ESCs and iPS cells of 3'UTR length (Ji and Tian, 2009) , heightened promoter occupancy in target genes for Oct4, Sox2 and Nanog (Huang et al., 2009 ) and differences in the DNA methylomes (Doi et al., 2009; Pick et al., 2009) . Differences in 3'UTR length through the use of alternative polyadenylation sites may affect the presence of cisregulatory elements for mRNA stability and/or translatability (Ji and Tian, 2009 ) and lead to post-transcriptional changes in the proteome of iPSC compared to ESCs. A more than 10-fold increased promoter occupancy observed in high fidelity iPSCs as judged by traditional assays, affects four signaling pathways specifically in iPSCs (Huang et al., 2009 ) and further investigation is needed to determine its significance in the context of pluripotency. The differences in the DNA-methylomes of human iPS cells compared to ES cells are significant and affect both imprinted genes (Pick et al., 2009) and loci encoding gene products essential to developmental processes (Doi et al., 2009) . These included the Dlk1-Dio3 gene cluster in mice, which contains maternally expressed genes, Gtl2, Rian and Mirg, and the paternally expressed genes, Dlk1 and Dio3 (Stadtfeld et al., 2010) , and region p15 on chromosome 11 in man, containing the H19, IGF2, and KCNQ10T1 genes implicated in hyperplasia and Beckwith-Wiedemann syndrome (Pick et al., 2009) . Finally, other observed DNA methylation divergences consisted of 71 loci showing differential DNA-methylation in iPS cells compared to ES cells and nearly half of these were located near genes such as HOXA9, ZBF568, ZFP112, PTPRT (a multi-functional tyrosine phosphatase) and TBX5, a transcription factor essential for cardiac and limb development (Doi et al., 2009) . Notably, imprinting defects appear to be associated with increasing passage numbers of the source cells used for reprogramming (Pick et al., 2009 ), but no data exist for DNA methylation divergences among other loci.
Summary and outlook
Both natural and artificial routes to pluripotency depend on the master pluripotency factors Oct4, Sox2 and Nanog and also share molecular features such as restructuring of the nuclear organization. Both routes employ a biphasic mechanism: During gametogenesis concerted chromatin remodeling occurs, predisposing it to pluripotency. Upon fertilization, Oct4, Sox2 and Nanog expression is induced, resulting in the activation of the downstream pluripotency transcription network. Similarly, ectopic expression of Oct4, Sox2 and Nanog may produce a pseudozygotic state during artificial reprogramming but conversely, this state is devoid of chromatin poised for pluripotency. Forced prolonged expression of Oct4, Sox2 and Nanog is necessary for somatic cells to enter the pluripotent state and it is likely that the orchestrated events during gametogenesis that yield the chromatin poised for pluripotency occur now in a stochastic fashion. Moreover, the start of chromatin remodeling occurs in an inverse order with respect to the cellular presence of Oct4, Sox2 and Nanog. An implication might be that chromatin modifiers that are active during gametogenesis may also function as additional reprogramming factors during iPS, perhaps improving efficiency and/ or fidelity.
The stochastic mechanism during artificial reprogramming is consistent with the observed inefficiency of artificial reprogramming and the realization that increasing numbers of previously deemed bona fide iPS cells reside in an aberrant epigenetic state due to the partial retention of somatic chromatin that is initially dispensable for pluripotency. In utero, gametocyte fitness and embryo survival is dependent on appropriate chromatin remodeling, providing a stringent quality control mechanism. In vitro, no such mechanism exists and current criteria may prove to be inadequate for the certification of clinical grade iPSCs. Novel culture conditions and tests capable of scanning for molecular variance between ES cells and iPS cells at high resolution may all be required to resolve these issues. BALHORN, R., REED, S. and TANPHAICHITR, N. (1988) . Aberrant protamine 1/ protamine 2 ratios in sperm of infertile human males. Experientia 44: 52-55.
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